Opportunity Information: Apply for RFA MH 25 125

This funding opportunity is an NIH R34 planning and pilot grant (RFA-MH-25-125; CFDA 93.242) focused on reducing suicide ideation, attempts, and related behaviors among youth from underserved populations by improving how real-world service systems detect risk and respond to it. The program is designed to fund early-stage research that can show whether a proposed approach is feasible, acceptable to youth and families and the settings that serve them, and safe to implement. It also supports gathering the kind of preliminary data that would be needed to justify a later, larger efficacy or effectiveness study. The emphasis is on practical, scalable strategies that can be used in the community settings where at-risk youth are most likely to show up for help, especially in under-resourced environments.

The core expectation is that applicants will develop and pilot-test a multi-level, service system intervention rather than a single standalone clinical technique. In plain terms, the intervention should improve the entire pathway from identifying suicide risk to evaluating it appropriately and then linking young people to the right level of care and supports. The NOFO highlights coordination across steps and across roles, meaning the work should address how organizations and staff members communicate, make decisions, and ensure follow-through. The goal is not simply to detect risk, but to ensure that detection leads to timely, effective action that reduces suicide risk and suicidal behavior for a specifically defined at-risk youth group.

The opportunity lays out three main goals for proposed projects. First, teams should design an intervention that coordinates suicide risk identification, evaluation, and linkage to treatment and services for a clearly identified youth population at elevated risk, with the approach tailored to the risk profile and context of that group. Second, the project should test feasibility and initial effectiveness for detecting and reducing suicide risk and suicidal behavior in that population, which typically means demonstrating that the approach can actually be carried out in the intended setting and that early signals of benefit are measurable. Third, applicants must demonstrate how the intervention can be implemented in underserved, under-resourced community settings and show credible potential for future uptake, which pushes teams to consider training, workflow integration, staffing realities, sustainability, and other real implementation constraints from the start.

A key boundary in the announcement is that it is not meant to fund the creation of new screening tools or new assessment instruments. The scientific and practical focus is on systems-level interventions that improve outcomes using evidence-based strategies for detection, triage, engagement, referral, linkage, and follow-up. In other words, the work should strengthen or redesign processes across service systems (such as schools, primary care, emergency departments, community mental health, child welfare, juvenile justice, or other youth-serving settings) rather than inventing a brand-new screening questionnaire. Clinical trials are optional under this R34, which means applicants can propose a design that includes a clinical trial component if appropriate, but they are not required to do so.

Eligibility is broad and includes many types of U.S.-based organizations and governments that commonly touch youth services. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses. The NOFO explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, and certain regional organizations, reflecting the program's emphasis on reaching underserved populations through trusted institutions and local infrastructure.

There are also clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them) are not allowed. The funding instrument is a grant, the sponsoring agency is the National Institutes of Health, and the original closing date listed for this opportunity was February 20, 2024. Overall, the opportunity is aimed at building practical, coordinated, and implementable service-system solutions that can quickly identify youth at risk for suicide and ensure they receive effective, connected care in the places they are most likely to seek help.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2023-09-01.
  • Applicants must submit their applications by 2024-02-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 25 125

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)

Previous opportunity: 4-H Military Extension Educator Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 25 125

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 25 125) also looked into and applied for these:

Funding Opportunity
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) Apply for RFA MH 25 126

Funding Number: RFA MH 25 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed) Apply for RFA HL 24 015

Funding Number: RFA HL 24 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed) Apply for RFA HL 24 016

Funding Number: RFA HL 24 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,260,000
High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional) Apply for RFA AG 24 034

Funding Number: RFA AG 24 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
State Dementia Care Research Center (U54 Clinical Trial Not Allowed) Apply for RFA AG 24 033

Funding Number: RFA AG 24 033
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) Apply for RFA MH 24 320

Funding Number: RFA MH 24 320
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: The Harmonized Cognitive Assessment Protocol (HCAP) Network (U24 Clinical Trial Not Allowed) Apply for RFA AG 24 035

Funding Number: RFA AG 24 035
Agency: National Institutes of Health
Category: Health
Funding Amount: $385,000
Kenya Digital Health Ecosystem Activity Apply for 72061523RFI00001

Funding Number: 72061523RFI00001
Agency: Kenya USAID-Nairobi
Category: Health
Funding Amount: $20,000,000
Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed) Apply for RFA MH 24 322

Funding Number: RFA MH 24 322
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) Apply for PAR 23 300

Funding Number: PAR 23 300
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 056

Funding Number: RFA AI 23 056
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 017

Funding Number: RFA RM 23 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 016

Funding Number: RFA RM 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,875,000
Human Virome Characterization Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 019

Funding Number: RFA RM 23 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 018

Funding Number: RFA RM 23 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 23 305

Funding Number: PAR 23 305
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 23 307

Funding Number: PAR 23 307
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 332

Funding Number: RFA MH 24 332
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) Apply for RFA MD 24 003

Funding Number: RFA MD 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 23 301

Funding Number: PAR 23 301
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 25 125", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: